*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter - as a primary diagnosis code | T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.34 | |
| Readmission Rate (%) | 24.76 | |
| Unplanned Readmission Rate (%) | 16.06 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 101,548 | |
| Total Hospitalizations with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 205 | |
| DRG Share of Total Hospitalizations | 0.31 | |
| % of Total ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 56.63 | |
| Avg LOS at DRG | 4.68 | |
| Avg LOS with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 4.24 | |
| Readmission Rate at DRG | 32.74 | |
| Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 25.87 | |
| Unplanned Readmission Rate at DRG | 13.79 | |
| Unplanned Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 20.4 | |
| Total Medicare payments at DRG | $922,969,291 | |
| Total Medicare payments with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $1,752,637 | |
| Total Medicare payment per Day at DRG | $1,941 | |
| Total Medicare payment per Day with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $2,017 | |
| Total Medicare payment per Hospitalization at DRG | $9,089 | |
| Total Medicare payment per Hospitalization with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $8,549 | |
| Total Medicare Charges at DRG | $4,727,523,206 | |
| Total Medicare Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $6,760,016 | |
| Avg Charges at DRG | $46,555 | |
| Avg Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $32,976 | |
| Mortality Rate at DRG | 2.95 | |
| Mortality Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | NA | |
| SNF Discharge Rate at DRG | 13.87 | |
| SNF Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 35.61 | |
| Home Discharge Rate at DRG | 43.04 | |
| Home Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 38.54 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 122,730 | ||||
| Total Hospitalizations with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 3,246 | ||||
| DRG Share of Total Hospitalizations | 0.37 | ||||
| % of Total ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 7.75 | ||||
| Avg LOS at DRG | 7.61 | ||||
| Avg LOS with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 3.72 | ||||
| Readmission Rate at DRG | 21.31 | ||||
| Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 20.69 | ||||
| Unplanned Readmission Rate at DRG | 14.13 | ||||
| Unplanned Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 12.81 | ||||
| Total Medicare payments at DRG | $1,397,885,220 | ||||
| Total Medicare payments with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $18,296,343 | ||||
| Total Medicare payment per Day at DRG | $1,497 | ||||
| Total Medicare payment per Day with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $1,516 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,390 | ||||
| Total Medicare payment per Hospitalization with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $5,637 | ||||
| Total Medicare Charges at DRG | $4,175,290,309 | ||||
| Total Medicare Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $93,810,224 | ||||
| Avg Charges at DRG | $34,020 | ||||
| Avg Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $28,900 | ||||
| Mortality Rate at DRG | 0.28 | ||||
| Mortality Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 21.64 | ||||
| SNF Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 29.39 | ||||
| Home Discharge Rate at DRG | 28.06 | ||||
| Home Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 36.66 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 885: PSYCHOSES | DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,100,860 | ||||
| Total Hospitalizations with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 1,202 | ||||
| DRG Share of Total Hospitalizations | 3.35 | ||||
| % of Total ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 2.87 | ||||
| Avg LOS at DRG | 11.86 | ||||
| Avg LOS with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 19.4 | ||||
| Readmission Rate at DRG | 27.58 | ||||
| Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 27.74 | ||||
| Unplanned Readmission Rate at DRG | 13.34 | ||||
| Unplanned Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 13.78 | ||||
| Total Medicare payments at DRG | $9,312,828,663 | ||||
| Total Medicare payments with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $16,113,428 | ||||
| Total Medicare payment per Day at DRG | $713 | ||||
| Total Medicare payment per Day with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $691 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,460 | ||||
| Total Medicare payment per Hospitalization with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $13,406 | ||||
| Total Medicare Charges at DRG | $32,341,464,302 | ||||
| Total Medicare Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $72,488,136 | ||||
| Avg Charges at DRG | $29,378 | ||||
| Avg Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $60,306 | ||||
| Mortality Rate at DRG | 0.04 | ||||
| Mortality Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 5.83 | ||||
| SNF Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 8.65 | ||||
| Home Discharge Rate at DRG | 79.47 | ||||
| Home Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 69.3 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,013,774 | ||||
| Total Hospitalizations with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 797 | ||||
| DRG Share of Total Hospitalizations | 3.08 | ||||
| % of Total ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 1.9 | ||||
| Avg LOS at DRG | 5.34 | ||||
| Avg LOS with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 6.48 | ||||
| Readmission Rate at DRG | 28.25 | ||||
| Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 30.43 | ||||
| Unplanned Readmission Rate at DRG | 21.93 | ||||
| Unplanned Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 22.83 | ||||
| Total Medicare payments at DRG | $9,469,067,156 | ||||
| Total Medicare payments with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $7,615,979 | ||||
| Total Medicare payment per Day at DRG | $1,751 | ||||
| Total Medicare payment per Day with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $1,475 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,340 | ||||
| Total Medicare payment per Hospitalization with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $9,556 | ||||
| Total Medicare Charges at DRG | $43,343,716,813 | ||||
| Total Medicare Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $37,627,375 | ||||
| Avg Charges at DRG | $42,755 | ||||
| Avg Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $47,211 | ||||
| Mortality Rate at DRG | 3.72 | ||||
| Mortality Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 3.14 | ||||
| SNF Discharge Rate at DRG | 20.84 | ||||
| SNF Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 31.37 | ||||
| Home Discharge Rate at DRG | 37.68 | ||||
| Home Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 27.85 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 58,218 | ||||
| Total Hospitalizations with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 587 | ||||
| DRG Share of Total Hospitalizations | 0.18 | ||||
| % of Total ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter in DRG | 1.4 | ||||
| Avg LOS at DRG | 7.4 | ||||
| Avg LOS with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 4.38 | ||||
| Readmission Rate at DRG | 26.4 | ||||
| Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 27.95 | ||||
| Unplanned Readmission Rate at DRG | 19.51 | ||||
| Unplanned Readmission Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 19.96 | ||||
| Total Medicare payments at DRG | $694,366,430 | ||||
| Total Medicare payments with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $4,337,102 | ||||
| Total Medicare payment per Day at DRG | $1,611 | ||||
| Total Medicare payment per Day with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $1,686 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,927 | ||||
| Total Medicare payment per Hospitalization with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $7,389 | ||||
| Total Medicare Charges at DRG | $2,299,290,199 | ||||
| Total Medicare Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $20,002,999 | ||||
| Avg Charges at DRG | $39,494 | ||||
| Avg Charges with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | $34,077 | ||||
| Mortality Rate at DRG | 2.37 | ||||
| Mortality Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 20.38 | ||||
| SNF Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 31.18 | ||||
| Home Discharge Rate at DRG | 26.95 | ||||
| Home Discharge Rate with ICD T426X5A - Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter | 33.9 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 130 |
| NEW HANOVER REGIONAL MEDICAL CENTER | 2131 S 17TH ST | WILMINGTON | NC | 28401 | 127 |
| BETH ISRAEL DEACONESS MEDICAL CENTER | 330 BROOKLINE AVE | BOSTON | MA | 02215 | 118 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 35 |
| Dr. HARBHAJAN S PARMAR | 36100 EUCLID AVE | WILLOUGHBY | OH | 44094 | 14 |
| Dr. TED KASPAR | 1900 N 14TH ST | PONCA CITY | OK | 74601 | 14 |